Document is current
Any future updates will be listed below
-
Authors
Degerlund-Maldi, Kinza
Regardt, Malin
Nystrand Länsman, Camilla
Larsson, Lena
Parodis, Ioannis
Heintz, Emelie
-
Funding
Funding for this research was provided by:
Karolinska Institute
- License Information
-
More Information
Article History
Received: 19 September 2025
Accepted: 19 January 2026
First Online: 7 February 2026
Declarations
:
: K.D.M. is a member of the EuroQoL PhD Network. I.P. has received funding and honoraria from Amgen, AstraZeneca, Aurinia Pharmaceuticals, Elly Lilly and Company, Gilead Sciences, BMS, GlaxoSmithKline, Janssen Pharmaceuticals, Novartis, Otsuka Pharmaceutical, and F. Hoffmann-La Roche AG, and consulting fees from BMS, AstraZeneca, Novartis, Otsuka, Roche, and Amgen. E.H. has received funding from EuroQol Research Foundation and The Swedish Rheumatism Association. C.N.L. has received funding from The Swedish Rheumatism Association. L.L. and M.R. declared no competing interests.
